Maverick Capital’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-214,559	Closed	-$12.2M	–	370
2022 Q2	$12.2M	Sell	214,559 -104,969	-33%	-$6.62M	0.31%	49
2022 Q1	$25.8M	Sell	319,528 -68,646	-18%	-$10.2M	0.46%	47
2021 Q4	$78.7M	Sell	388,174 -1,054	-0.3%	-$229K	0.95%	27
2021 Q3	$105M	Buy	389,228 +5,156	+1%	+$1.24M	1.16%	24
2021 Q2	$98.9M	Sell	384,072 -6,482	-2%	-$1.79M	0.93%	22
2021 Q1	$117M	Sell	390,554 -53,154	-12%	-$16.5M	1.1%	17
2020 Q4	$113M	Buy	443,708 +65,160	+17%	+$16.8M	1.81%	21
2020 Q3	$94.2M	Buy	378,548 +32,772	+9%	+$10.3M	1.75%	19
2020 Q2	$120M	Buy	345,776 +19,216	+6%	+$6M	2.53%	13
2020 Q1	$87.4M	Buy	326,560 +110,478	+51%	+$34.2M	1.85%	15
2019 Q4	$70M	Buy	+216,082	New	+$62.7M	1.02%	22